Screening in liver disease: Report of an AASLD clinical workshop
Paul C. Adams(Western University), Leonard B. Seeff(National Institute of Diabetes and Digestive and Kidney Diseases), Mark A. Hall(Pacific Northwest National Laboratory), Adrian M. Di Bisceglie(Saint Louis University), Laurie D. DeLeve(University of Southern California), Theodore R. Levin(Kaiser Permanente), Michael J.P. Arthur(University of Southampton), Thomas Boyer(Centre Hospitalier Universitaire Amiens-Picardie), Dawn Provenzale(Michael E. DeBakey VA Medical Center)
Cited by 58
Related Papers
Diagnosis, management, and treatment of hepatitis C: An update # † ‡
|Hepatology|2008|3k
Diagnosis, management, and treatment of hepatitis C†
|Hepatology|2004|1.7k
Design and Endpoints of Clinical Trials in Hepatocellular Carcinoma
|JNCI Journal of the National Cancer Institute|2008|1.7k
Ledipasvir and Sofosbuvir for 8 or 12 Weeks for Chronic HCV without Cirrhosis
|New England Journal of Medicine|2014|1.1k
Serum markers detect the presence of liver fibrosis: A cohort study
|Gastroenterology|2004|1.1k